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http:WHAT THIS PAPER ADDS
This study questions whether young patients are better served with endovascular or open repair of an
abdominal aortic aneurysm in the elective setting. This research question is important in the light of the recently
introduced national screening programme, as a greater number of young patients will present electively for
repair. One of the main criticisms of endovascular repair has been lack of long-term durability with the need for
life-long surveillance and a signiﬁcant number of late reinterventions. Few studies have described long-term
complications following open repair. This study speciﬁcally examines outcomes in young patients and include
long-term reinterventions following both open and endovascular repair.Objective: The lower procedural risk associated with endovascular aneurysm repair (EVAR) compared with open
aneurysm repair (OAR) is well known. Younger patients are likely to represent a group at low perioperative risk.
The long-term durability and late complications following EVAR may have more signiﬁcance when considering the
optimal treatment for young patients with a longer life expectancy. This study examined perioperative and long-
term outcomes of young patients undergoing aneurysm repair by either open surgical or endovascular means.
Methods: A retrospective review of a prospectively collated database was performed. Patients undergoing
elective aneurysm repair at the age of 65 years or younger between January 2000 and September 2010 were
included. All EVAR patients were followed up in a nurse-led clinic. Data regarding long-term outcomes for
patients undergoing open repair were gathered from case note review.
Results: There were 99 patients who underwent open repair and 59 patients who underwent endovascular
repair. Groups were well matched in terms of demographics and co-morbidities. 30-day mortality was 1% after
open repair. There were no perioperative deaths after endovascular repair. Overall, 30-day complication rates
were 15% after open repair and 12% after EVAR. The nature of complications differed between the two groups
with the EVAR group experiencing endoleaks and the OAR group demonstrating more cardiorespiratory
complications. Mean follow-up was 75.5 months and there was a 14% reintervention rate after EVAR compared
with 7% after OAR.
Conclusion: Young patients are likely to have a lower procedural risk for EVAR and OAR than described in
published ﬁgures. Although mortality and complication rates in these two groups were similar, the nature of
complications occurring following open surgery were often more signiﬁcant than those occurring after EVAR.
There remains a risk of late reintervention following either form of repair.
 2013 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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The introduction of endovascular aneurysm repair (EVAR)
has revolutionised aneurysm treatment in the UK. This has
been associated with reduced aneurysm related mortality in
recent years, with an increase in elective EVAR especially
in those aged over 75 years.1 The signiﬁcantly lowerrresponding author. R.M. Sandford, University Hospitals of Leicester,
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//dx.doi.org/10.1016/j.ejvs.2013.09.014perioperative morbidity and mortality of EVAR compared
with open aneurysm repair (OAR) have been well docu-
mented in large multicentre trials;2,3 however, the early
advantage gained in terms of reduced perioperative com-
plications is offset by a risk of late complications (endoleak,
device migration, etc.) and the need for postoperative
surveillance.
Current practice has moved on since the EVAR trials were
performed, with clinician experience and device design
improving towards a more durable repair. The issue of EVAR
durability is of particular importance when considering
younger patients with greater life expectancy, particularly as
reinterventions are thought to have a negative impact on
14 R.M. Sandford et al.survival.4 Recent debate has focussed on the longer-term
progression of aneurysmal disease. It is apparent that a
proportion of patients may go on to further aneurysmal
dilatation despite successful repair by either endovascular
or open surgical means.5
With the introduction of the National Aneurysm
Screening Programme throughout the UK in 2011e12, a
large number of 65-year-old men are likely to be considered
for aneurysm repair. This cohort may have less signiﬁcant
co-morbid disease and potentially pose a lower periopera-
tive risk for either EVAR or OAR.6 They may also be
reasonably assumed to have a longer life expectancy than
those in the EVAR trial, in whom the mean age was 74
years. It is not yet known whether the multicentre trial data
are directly applicable to this selected, younger group of
patients.
This retrospective review examined outcome data for
patients aged 65 years and under from a single centre and
the results are presented.Table 1. Early complications within 30 days following OAR and
EVAR.
OAR
(n ¼ 99)
EVAR
(n ¼ 59)
p (Fisher’s
Exact Test)
Chest infectiona 5 (5%) 1 (2%) .42
Acute limb ischaemiab 2 (2%) 0 .53
Cardiac arrhythmiac 2 (2%) 0 .53
Haemorrhaged 1 (1%) 0 .99
Mesenteric ischaemiae 1 (1%) 0 .99
Acute coronary syndromef 3 (3%) 0 .29
Renal failureg 0 1 (2%) .38
Sepsish 1 (1%) 0 .99
Endoleak 0 5 (8%) .008
Type 1 2
Type 2 3
EVAR ¼ endovascular aneurysm repair; OAR ¼ open aneurysm
repair.
a A clinical diagnosis of chest infection was made if the patient had
a raised respiratory rate, hypoxia, fever, and x-ray changes sug-
gestive of infection requiring treatment.
b Acute limb ischaemia was deﬁned as sudden onset of limb-
threatening ischaemia requiring urgent intervention.
c Cardiac arrhythmia was considered to be any new onset of a
rhythm abnormality requiring treatment in the postoperative
period.
d Haemorrhage requiring resuscitation with blood products and
return to theatre to achieve haemostasis.
e Mesenteric ischaemia related to non-viable ischaemic injury to
the left colon requiring emergency colectomy.
f The acute coronary syndrome was deﬁned as chest pain with an
ECG compatible with ischaemia and/or a diagnostic troponin rise.
g Renal failure was deﬁned as requiring dialysis.
h Sepsis was deﬁned as an acute inﬂammatory response with
bacteraemia.METHODS
Records were kept for all patients undergoing either OAR or
EVAR between January 2000 and September 2010. Data
were recorded prospectively and included demographic and
co-morbidity information in addition to 30-day outcomes.
Patients participating in the EVAR trial are included in this
dataset, and so a combination of randomised and selected
patients were studied.
In order to assess ﬁtness for surgery, patients underwent
routine haematological and biochemical blood screening,
spirometry, electrocardiography, and echocardiography.
Patients were then assessed in a preoperative clinic by a
consultant vascular anaesthetist and a detailed functional
history was obtained in addition to clinical examination.
Following this, a pragmatic judgement was made regarding
ﬁtness for OAR and EVAR on clinical grounds rather than on
predeﬁned objective criteria This is in keeping with the
methodology of the EVAR trials taking place during the
same time period.
Decisions regarding choice of repair in patients who were
considered ﬁt for both OAR and EVAR were made in two
ways. During the period of recruiting for the UK EVAR 1
trial, patients were consented appropriately and rando-
mised according to the study protocol. After this time
period, a full discussion was undertaken between the
consultant vascular surgeon and the patient regarding the
risks and rationales of each technique and a ﬁnal agreement
was reached regarding choice of surgery.
Following surgery, patients underwent pre-discharge
duplex ultrasound scan (DUSS) and were subsequently
seen for outpatient review at 6 weeks, 3 months, 6
months, and 6-monthly intervals thereafter. Beyond the
ﬁrst outpatient visit, all reviews took place in a specialist
nurse-led clinic and consisted of clinical review including
history, clinical examination, blood tests, abdominal x-ray
and duplex imaging. In cases where there was concern
regarding graft function, for example duplex imagingsuggestive of endoleak or abdominal tenderness on ex-
amination, patients were reviewed by a clinician and
further imaging with CT angiogram arranged as appro-
priate. All imaging was discussed in a multidisciplinary
meeting.
All data were collected contemporaneously by the
specialist nurses. A retrospective review of this database
was conducted, including only patients who were 65 years
or younger at the time of surgery and undergoing elective
repair.
Data regarding patients undergoing OAR were collected
from the department prospective database which holds
outcome data for the ﬁrst 30 days. Longer-term outcomes
were obtained by case note review.
Clinical variables relating to co-morbidity and complica-
tion data were gathered from case notes. Co-morbidities
such as hypertension, hyperlipidaemia, ischaemic heart
disease, and diabetes were considered present if the pa-
tient reported a history of the illness on admission clerking
(corroborated by GP records) and was receiving treatment
for that condition. The various postoperative complications
were recorded as documented in case notes. Standard
clinical deﬁnitions used are given in the footnotes to
Table 1.
Table 2. Co-morbidity data for patients undergoing EVAR.
OAR
(n ¼ 99)
EVAR
(n ¼ 59)
p (chi-
square)
Smoking statusa
Current smoker 21 (21.2%) 14 (23.7%) .91
Ex-smoker 45 (45.5%) 37 (62.7%) .3
Never smoker 8 (8.1%) 2 (3.4%) .33 (Fisher’s
exact test)
Hyperlipidaemia 27 (27.3%) 26 (44.1%) .04
Hypertension 45 (45.5%) 34 (57.6%) .48
Diabetes 5 (5.1%) 7 (11.7%) .26
Type 1 0 4
Type 2 5 3
Renal failure 0 3 (5.1%) .05 (Fisher’s
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Continuous variables are described as mean or median and
dichotomous data as numbers and percentages. Categorical
data were compared using chi-square test for large numbers
and Fisher’s Exact Tests for variables with small numbers.
Standard survival analysis techniques (life-table analysis,
and log-rank tests) were used to compare freedom from
reintervention and time to reintervention between groups.
For all tests, a p value of less than .05 (two-sided) was
considered signiﬁcant. Statistical analyses were performed
using IBM SPSS statistical software (IBM, USA) (survival
analyses) and GraphPad Prism (chi-square, Fisher’s Exact
Test).exact test)
Previous MI 24 (24.2%) 19 (32.2%) .52
AAA diameter (cm)
(mean  SD (range))
6.6  1.17
(3.8be10)
6.4  0.99
(5.4e10)
.99
Infrarenal AAA 95 (96.0%) 56 (94.9%) 1 (Fisher’s
exact test)
Juxtarenal AAA 4 (4.0%) 3 (5.1%)
AAA ¼ abdominal aortic aneurysm; EVAR ¼ endovascular
aneurysm repair; MI ¼ myocardial infarction; OAR ¼ open
aneurysm repair.
a Data incomplete for 25 patients in OAR group and six patients in
the EVAR group.
b In ﬁve cases, a small aortic aneurysm was treated in association
with a larger common iliac aneurysm.RESULTS
There were 223 patients aged 65 years or younger who
underwent aneurysm repair between January 2000 and
September 2010 at our centre. One-hundred and ﬁfty-seven
patients underwent OAR and 66 patients underwent EVAR.
Of the total cohort, 65 patients underwent emergency
repair for a symptomatic or ruptured aneurysm and were
excluded from further analysis (Fig. 1). Ninety-nine patients
underwent elective OAR and 59 patients underwent elec-
tive EVAR.
Median age was 62 years (range 43e65) in the open
group and 61 years (range 37e65) in the EVAR group; 93
patients (94%) were male in the OAR group and 56 patients
(95%) were male in the EVAR group. Co-morbidity data are
given in Table 2.
The open repairs were performed via a transperitoneal
approach in all cases. There were 50 straight graft aorto-
aortic repairs (including ﬁve juxtarenal aneurysms) and 31
bifucated graft aorto-iliac repairs (including one juxtarenal
aneurysm requiring reimplantation of the renal arteries).
Operative data was missing as a result of archiving from 18
patients who underwent surgery prior to 2004. The EVAR
group included 54 bifurcated devices (including three
fenestrated devices) and ﬁve aorto uni-iliac devices.Figure 1. Patients undergoing abdominal aortic aneurysm (AThere was one perioperative (<30 days) death after OAR
and no deaths after EVAR. This difference was not statisti-
cally signiﬁcant (p ¼ .99). The death in the OAR group
occurred because of sepsis-related multi-organ failure at
day 12 following repair of a juxtarenal inﬂammatory aneu-
rysm using a bifurcated graft. There were 15 (15%) patients
who suffered a complication after OAR and seven (12%)
after EVAR (p ¼ .81). Details of complications are given in
Table 1. Most complications encountered following EVAR
were endoleaks; however, in contrast to this, the group
undergoing OAR experienced more signiﬁcant cardiorespi-
ratory complications. Of the two patients with a type 1AA) repair between January 2000 and September 2010.
Table 3. Early reinterventions (within 30 days) following open
repair.
Reintervention Indication for
reintervention
Embolectomy Acute limb ischaemia
Above knee amputation Acute limb ischaemia
Laparotomy and control of bleeding Haemorrhage
Sigmoid colectomy and formation
of end colostomy
Mesenteric ischaemia
Table 5. Late reinterventions (after 30 days) following elective
open repair (n ¼ 99).
Reintervention Reason/underlying
problem
Number of
patients (%)
Incisional hernia repair Incisional hernia 4 (4)
Endovascular relining of
graft to seal ﬁstula
Aorto-enteric ﬁstula 1 (1)
Graft excision and extra-
anatomical bypass
Graft infection 1 (1)
Femoropopliteal bypass Non-healing fasciotomy
wounds following
compartment syndrome
which complicated AAA
repair
1 (1)
AAA ¼ abdominal aortic aneurysm.
16 R.M. Sandford et al.endoleak following EVAR, one resolved spontaneously and
one returned to theatre for a proximal cuff extension. There
were four patients who required an early reintervention
following open surgery and these are detailed in Table 3.
Mean stay on the intensive care unit (ICU) for the OAR
group was 2.8 days (median 2 days; range 0e40 days, SD
4.26) after elective repair. In the EVAR group 14 of 59 pa-
tients were admitted to the ICU after elective repair (24%),
with a maximum stay of 2 days. Overall mean length of
hospital stay was 7 days in the EVAR group (median 5 days;
range 3e25 days, SD 4.55) and 12 days (median 9 days;
range 3e94 days, SD 12) in the OAR group.
Mean overall follow-up was 75.5 months (SD 44.6) with a
longer follow-up in the OAR group (93.3 months, SD 39.1)
than the EVAR group (35.4 months, SD 26.5). There was a
reintervention rate of 14% (eight patients) among the EVAR
group and details of reinterventions are given in Table 4.
Approximately 50% of these were for high-risk endoleaks
and were dealt with via endovascular means. The reinter-
vention rate among the group undergoing elective OAR was
7% (seven patients) and details are given in Table 5. Most of
these patients had developed incisional hernia, which were
subsequently repaired. The time to reintervention is shown
in Fig. 2. Freedom from reintervention at 1, 2, 3, and 5 years
was 99%, 98%, 95%, and 93% respectively in the OAR group.
In the EVAR group, freedom from reintervention at the
same time points was 93%, 89%, 84%, and 85% respectively
(p ¼ .02).DISCUSSION
This is a retrospective study comparing OAR and EVAR in a
group of patients aged 65 years and younger. It demon-
strates a low perioperative morbidity and mortality
compared with the major trials. This is not surprising givenTable 4. Late re-interventions (after 30 days) following elective
EVAR (n ¼ 59).
Reintervention Reason/underlying
problem
Number of
patients (%)
Cuff Proximal type 1
endoleak
3 (5)
Extension limb Distal type 1 endoleak 1 (2)
Cross over graft Limb occlusion 2 (3)
Graft limb
thrombectomy
Limb occlusion 1 (2)
Extra-anatomical graft Stent occlusion 1 (2)
EVAR ¼ endovascular aneurysm repair.the younger, ﬁtter population studied and is in keeping with
other studies reporting comparative series of young pa-
tients undergoing aneurysm repair.7
Although it is a non-randomised study, it does give a
preliminary account of outcomes among a young group
undergoing aneurysm repair. The EVAR group might be ex-
pected to compare favourably with the open repair group at
30 days, accounting for the known lower procedural risk
associated with EVAR; however in this series, EVAR did not
improve the perioperative mortality compared with open
repair in young patients. Although the early postoperative
complication rate between groups is similar, the nature of
those complications does vary between groups, with the
predominant endovascular complication being endoleak, a
proportion of which were type 2 endoleaks and therefore
considered benign. Among the OAR group, complications
were generally of a more signiﬁcant nature including hae-
morrhage, acute coronary syndromes, limb and mesenteric
ischaemia.
Longer term, a higher reintervention rate could be
anticipated among the EVAR group given the UK EVAR 1
trial data.8 However, the UK EVAR trial did not recordFigure 2. Time to reintervention following open or endovascular
aneurysm repair (EVAR). p ¼ .02 (log rank).
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Laparotomy-related late reinterventions have been re-
ported following OAR. The OVER trial reported a 13% sec-
ondary intervention rate at 9 years, with procedures
including incisional hernia repair, laparotomy for bowel
obstruction, and graft-related procedures.9 Similarly, the
Medicare study of over 22,000 patients in each cohort
found a laparotomy-related reintervention rate of 9.7% by 4
years following open repair, and 14% of patients required
laparotomy-related hospitalisation.10 Other studies have
also noted the signiﬁcant number of readmissions related to
OAR requiring no further surgery.11 Both this study, and a
recent publication examining mid-term outcomes following
EVAR,12 reiterate this often unreported risk of long-term
reinterventions following open repair.
Our data are in keeping with recent studies that report
15e20% of patients required a secondary procedure rate
following EVAR.13e15 Persistent endoleak and need for
reintervention are associated with risk of aneurysm rupture
and therefore must be considered signiﬁcant. However,
with the evolution of stent graft design and growing inter-
ventional experience, these ﬁgures are likely to be an
overestimate and not reﬂective of current or future
practice.
Few studies have investigated performance of endovas-
cular repair among different age groups. Those that have
concentrate on the elderly population, verifying that EVAR
remains a good treatment in this group.16,17 It is likely that
in coming years, there will be an increase in young patients
presenting via the screening programme for consideration
of aneurysm repair. The ﬁgures used to guide current dis-
cussion with patients are based on the UK EVAR trial data,
which gives 30-day mortality of 4.3% after OAR and 1.8%
after EVAR. In this series, the operative mortality is far
below this at less than 1% for elective cases. It is clear that
any intervention performed for a screen-detected aortic
aneurysm should carry with it the lowest possible risk to the
patient, and this can be justiﬁed on both ethical and
ﬁnancial grounds.
The method used to select patients ﬁt for OAR in this
study is fairly crude, and the introduction of newer tech-
nologies such as cardiopulmonary exercise testing (CPET)
has shown promising results.18,19 This may provide a better
guide towards ﬁtness for open surgery in the future.
In order to guide best practice and facilitate discussion
with patients, it will be necessary to investigate this area
more fully. Although this is a small, non-randomised study,
it does suggest a deviation from published ﬁgures among
the younger patients in terms of operative risk and re-
iterates the long-term implications of abdominal aortic
aneurysm repair by either open or endovascular surgery.Conclusions
In conclusion, this study demonstrates signiﬁcantly lower
morbidity and mortality among young patients undergoing
aneurysm repair by either open surgical or endovascular
means than previously reported. There remains a burden ofsigniﬁcant perioperative morbidity following open repair.
Longer-term reinterventions are seen following either type
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